COVID Testing

Coronavirus Disease 2019, or COVID-19, is a novel respiratory disease that has been characterized as a pandemic by the World Health Organization. Please visit WHO.INT for more information regarding COVID-19 prevention and guidelines.

 

​

RT-PCR TMA Details and Specifications

​

Our laboratories SARS-CoV-2 (COVID-19) assays include multiplex real-time RT-PCR and TMA intended for the qualitative detection of nucleic acid from SARS-CoV-2 in individuals meeting the Centers for Disease Control (CDC) COVID-19 clinical criteria (e.g., clinical signs and symptoms associated with SARS-CoV-2 infection) in conjunction with CDC COVID-19 epidemiological criteria or other epidemiologic criteria for which SARS-CoV-2 testing may be indicated. This test has been authorized by the FDA under an Emergency Use Authorization (EUA).

 

Our laboratories have been performing molecular infectious disease testing prior to the current COVID-19 health crisis. The decision to provide SARS-CoV-2 testing was the right thing to do for both our clients and the community.

​

​

COVID Antigen Testing

 

Antigen tests are immunoassays that detect the presence of a specific viral antigen, which implies current viral infection. Antigen tests are currently authorized to be performed on nasopharyngeal or nasal swab specimens placed directly into the assay's extraction buffer or reagent.

 

In general, antigen tests are very specific for COVID-19, but are not as sensitive as molecular PCR tests. This means that there is a higher chance of false negatives than with many molecular tests.

 

Antigen tests can be used for screening testing in high-risk congregate settings in which repeat testing could quickly identify persons with a SARS-CoV-2 infection to inform infection prevention and control measures, thus preventing transmission. In this case, and especially in settings where a rapid test turnaround time is required, there is value in providing immediate results with antigen tests, even though they may have lower sensitivity than NAATs.

​

​​

COVID Antibody Testing

​

COVID-19 IgG antibody testing, also known as serology testing, checks for a type of antibody called immunoglobulin G (IgG). If you have been exposed to the virus that causes COVID-19, your body typically produces IgG antibodies as part of the immune response to the virus.

​

​

COVID-19 IgG antibody testing, also known as serology testing, checks for a type of antibody called immunoglobulin G (IgG).

​

If you have been exposed to the virus that causes COVID-19, your body typically produces IgG antibodies as part of the immune response to the virus.

​

It can take at least two weeks after exposure to develop antibodies.

​

This type of COVID-19 test is for individuals who think they may have had COVID-19 and do not currently have symptoms.

​

You can get the IgG test ordered through your doctor or healthcare provider.

​

 

In accordance with the CARES Act, pricing for COVID-19 testing is $100/sample.

 

• Certified by CLIA

• Compliant with CDC and FDA Guidelines

• Results within 24-48 hours

​

​